Fulgent

Fulgent Genetics completes acquisition of Bako Diagnostics and StrataDx

Fulgent Genetics finalizes $56.9 million deal to expand pathology and dermatopathology capabilities with Bako Diagnostics and StrataDx Fulgent Genetics, Inc., a technology-driven company known for its strong laboratory services platform and growing therapeutic development efforts, has officially completed its previously…

Read MoreFulgent Genetics completes acquisition of Bako Diagnostics and StrataDx
WuXi Biologics

WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Bioprocessing, Manufacturing, and Digital Innovation Leadership

WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Advancements in Bioprocessing, Manufacturing Quality, and Digital Innovation WuXi Biologics a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual…

Read MoreWuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Bioprocessing, Manufacturing, and Digital Innovation Leadership

Johnson & Johnson Secures FDA Approval for TECNIS PureSee Intraocular Lens to Improve Cataract Vision in the U.S.

Johnson & Johnson Secures U.S. Food and Drug Administration Approval for TECNIS PureSee Intraocular Lens, Expanding Vision Care Options for U.S. Cataract Patients Johnson & Johnson announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth…

Read MoreJohnson & Johnson Secures FDA Approval for TECNIS PureSee Intraocular Lens to Improve Cataract Vision in the U.S.
Planet

Planet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry

Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026 Dental Industry Outlook, an annual benchmark report designed to help…

Read MorePlanet DDS 2026 Dental Outlook Reports More New Patients and Fewer No-Shows Across the Industry
C2N

C2N Diagnostics Expands to South Korea with BeauBrain Partnership for Precivity™ Tests

C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests for Alzheimer’s Diagnosis Specialty diagnostics company C2N Diagnostics has announced a strategic partnership with South Korea–based healthcare firm BeauBrain Healthcare to introduce…

Read MoreC2N Diagnostics Expands to South Korea with BeauBrain Partnership for Precivity™ Tests
United

United Therapeutics Corporation Publishes TETON-2 Phase 3 Trial Results

United Therapeutics Corporation Shares TETON-2 Phase 3 Trial Findings in The New England Journal of Medicine United Therapeutics Corporation announced that the complete findings from its Phase 3 TETON-2 clinical trial evaluating nebulized Tyvaso® (treprostinil) inhalation solution for the treatment…

Read MoreUnited Therapeutics Corporation Publishes TETON-2 Phase 3 Trial Results